Clinical Associate Professor University of North Carolina at Chapel Hill Durham, North Carolina, United States
Disclosure(s):
Kimberly A. Sanders, PharmD, BCPS: No financial relationships to disclose
Join your fellow dental healthcare professionals for an informative session designed to equip you with the latest insights into diabetes medication management. You’ll explore the integration of new medications, including glucagon-like peptide-1 (GLP-1) agonists and sodium-glucose co-transporter-2 (SGLT2) inhibitors. The session will cover updates to the American Diabetes Association guidelines, review medications with weight loss indications and highlight key dental considerations essential for effective patient care.
Learning Objectives:
Discuss the latest diabetes guidelines related to medication management and their implications for dental care
Describe how the newer diabetes medications (GLP-1 agonists and SGLT-2 inhibitors) and weight loss medications fit into overall management and their dental considerations
Identify the appropriate questions to ask patients about their diabetes management and apply these considerations to patient case scenarios if time permits
